Novapure
诺普再生
Novapure (诺普再生) is a Chinese medical technology company working on clinical applications of 3D printing based on bioregenerative materials — co-founder and CEO Dr. Yang Xi gave a keynote on exactly that topic at the 2025 China Biomedical Engineering Conference . It is a Qiming Venture Partners portfolio company, and Yang Xi was named an annual healthcare innovation entrepreneur on the 2025 Future Healthcare 100 list . Beyond that — founding date, funding history, team — elsewhere's corpus doesn't have dedicated coverage of the company itself; it appears mainly through Qiming Venture Partners' portfolio updates.
AI-generated — may contain errors, please verify.
Coverage
Qiming Weekly | Qiming Venture Partners Portfolio Companies Funding and Updates Vol. 23, 2025
Celebrating milestone moments with Qiming Venture Partners' portfolio companies
Qiming Weekly | Qiming Venture Partners Portfolio News and Updates Vol. 16, 2025
Celebrating milestone moments with Qiming Venture Partners' portfolio companies
Qiming Venture Partners and 50+ portfolio companies named to 2025 Future Healthcare 100 list
These rankings and reports aim to document the year's industry breakthroughs and reveal the growth patterns of listed companies and evolving industry trends, offering a reference for healthcare enterprises and entrepreneurs.
Steadfast Progress, Grounded in Action | Dalton Venture's 2024 Year in Review
Looking back at 2024, "adjustment" and "patience" became the defining keywords for venture capital. Yet on the long-distance track of life sciences and medtech, Dalton Venture kept moving forward with steady, deliberate strides. We navigated market fluctuations, caught glimpses of innovation, and helped companies take root and grow through the cycles — writing a new chapter of innovation-driven development with the power of capital.
